About Us

Committed to helping our partners enhance the safety and efficacy of TCR immunotherapies


Company Overview

Structured Immunity’s mission is to accelerate and de-risk the development of T cell receptor based therapeutics.

Founded in 2017, Structured Immunity provides  global expertise in structural biology and the most advanced structure based TCR validation and optimization platform available today.

Armed with this technology, Structured Immunity aims to serve the many groundbreaking biopharmaceutical companies in the industry, supporting the therapeutic development process by offering a suite of industry leading solutions.


Meet The Team


David Hardwicke President


Timothy Riley, PhD. Chief Scientific Officer


Brian Baker, PhD. Scientific Adviser